Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
235 studies found for:    Open Studies | bone marrow transplantation
Show Display Options
Rank Status Study
1 Recruiting Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer
Condition: Prostate Cancer
Interventions: Procedure: Bone marrow transplantation;   Drug: Bone marrow cell;   Drug: Cytoxan and testosterone
2 Recruiting Autologous Bone Marrow Transplantation (BMT) Compared With Allogeneic BMT in Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Procedure: Autologous bone marrow transplantation;   Procedure: Allogeneic bone marrow transplantation
3 Not yet recruiting Safety and Efficacy of an Immunoablative Nonmyeloablative Conditioning Protocol for Autologous Bone Marrow Transplantation (BMT) in Patients With Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Interventions: Procedure: Autologous bone marrow transplantation;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Drug: Alemtuzumab
4 Recruiting Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)
Conditions: Fibrolamellar Hepatocellular Carcinoma;   Hepatocellular Carcinoma (Fibrolamellar Variant);   Hepatocellular Carcinoma
Interventions: Procedure: living related donor partial liver transplantation;   Radiation: Total body irradiation;   Procedure: Bone marrow transplant from same donor;   Drug: Cyclophosphamide;   Drug: Mesna;   Drug: Filgrastim;   Drug: Tacrolimus;   Drug: mycophenolate mofetil;   Drug: Prednisone;   Drug: Antithymocyte globulin;   Drug: fludarabine
5 Recruiting Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)
Condition: Sickle Cell Disease
Interventions: Drug: Busulfan;   Drug: Fludarabine;   Drug: r-ATG;   Procedure: Bone Marrow Transplant;   Drug: Tacrolimus;   Drug: Methotrexate;   Procedure: Standard of Care
6 Recruiting Non-Myeloablative Conditioning and Bone Marrow Transplantation
Conditions: Sickle Cell Disease;   Hemoglobinopathies
Interventions: Drug: Thymoglobulin;   Drug: Fludarabine;   Drug: Cyclophosphamide (CTX);   Drug: Mesna;   Drug: Sirolimus;   Drug: Mycophenolate mofetil (MMF);   Procedure: Bone marrow transplantation;   Radiation: Total body irradiation
7 Recruiting Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia
Condition: Severe Aplastic Anemia
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: Total Body Irradiation;   Drug: Rabbit ATG
8 Recruiting Eltrombopag in Cord Blood or Haploidentical Bone Marrow Transplantation
Condition: Blood And Marrow Transplantation
Intervention: Drug: Eltrombopag
9 Recruiting Donor Human Milk in Young Children Receiving Bone Marrow Transplantation
Condition: Bone Marrow Transplant - Autologous or Allogeneic
Intervention: Biological: Breastmilk
10 Recruiting Double Cord Versus Haploidentical (BMT CTN 1101)
Conditions: Acute Lymphocytic Leukemia;   Acute Myelogenous Leukemia;   Burkitt's Lymphoma;   Follicular Lymphoma;   Hodgkin Lymphoma;   Mantle Cell Lymphoma;   Non-Hodgkin Lymphoma
Interventions: Biological: Haploidentical Bone Marrow Transplant;   Biological: Double Umbilical Cord Blood Transplant
11 Recruiting Autologous Unselected Hematopoietic Stem Cell Transplantation for Refractory Crohn's Disease
Conditions: Crohn Disease;   Inflammatory Bowel Diseases;   Gastroenteritis
Intervention: Procedure: Autologous Hematopoietic Stem Cell Transplantation
12 Recruiting HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide
Conditions: Myelodysplastic Syndrome (MDS);   Chronic Lymphocytic Leukemia (CLL);   Chemotherapy-sensitive Lymphoma;   Acute Lymphoblastic Leukemia (ALL)/T Lymphoblastic Lymphoma;   Acute Myelogenous Leukemia (AML);   Acute Biphenotypic Leukemia (ABL);   Acute Undifferentiated Leukemia (AUL)
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide 14.5 mg/kg/day IV on Days -6, -5;   Radiation: Total Body Irradiation (TBI) 200cGy on Day -1;   Procedure: Infusion of non-T-cell depleted bone marrow on Day 0;   Drug: Busulfan;   Drug: Cyclophosphamide 50mg/kg/day IV on Days -2,-1;   Drug: Cyclophosphamide 50mg/kg/day IV on Days -5,-4;   Radiation: Total Body Irradiation (TBI) 200cGy twice a day on Days -3, -2, -1;   Drug: Post-HCT Cyclophosphamide 50mg/kg IV on Day+3, +4;   Drug: Sirolimus;   Drug: Mycophenolate mofetil;   Drug: G-CSF;   Drug: Pre-HCT Mesna on Days -6 and -5;   Drug: Pre-HCT Mesna on Days -2 and -1;   Drug: Pre-HCT Mesna on Days -5 and -4;   Drug: Post-HCT Mesna
13 Recruiting Haploidentical Bone Marrow Stem Cell Transplantation in Patients With Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Procedure: Donor Bone Marrow stem cell transplantation
14 Recruiting HLA-Identical Sibling Donor Bone Marrow Transplantation for Individuals With Severe Sickle Cell Disease Using a Reduced Intensity Conditioning Regimen
Condition: Sickle Cell Disease
Intervention: Drug: Fludarabine monophosphate
15 Recruiting Ofatumumab & Ibrutinib + Allogeneic Bone Marrow Transplant or Consolidation in High Risk Chronic Lymphocytic Leukemia
Condition: Leukemia, Lymphoblastic, Chronic
Intervention: Drug: Ibrutinib + ofatumumab
16 Recruiting Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)
Condition: Juvenile Myelomonocytic Leukemia
Interventions: Biological: Stem Cell Transplant;   Drug: Preparative Regimen
17 Recruiting Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide
Conditions: Hodgkin's Lymphoma;   Leukemia;   Myelodysplastic Syndrome(MDS);   Multiple Myeloma;   Non Hodgkin's Lymphoma
Intervention: Procedure: Bone Marrow Transplant
18 Recruiting Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy
Conditions: Leukemia;   Myelogenous;   Chronic;   BCR-ABL Positive
Interventions: Drug: Bosutinib;   Procedure: Bone Marrow Transplant;   Drug: Bone Marrow cells
19 Recruiting Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
Conditions: Acute Myeloid Leukemia;   Myelodysplastic Syndrome
Intervention: Drug: Lenalidomide
20 Recruiting Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases
Conditions: Severe Combined Immunodeficiency (SCID);   Immunodeficiency With Predominant T-cell Defect, Unspecified;   Severe Chronic Neutropenia;   Chronic Granulomatous Disease (CGD);   Hyper IgE Syndromes;   Hyper IgM Deficiencies;   Wiskott-Aldrich Syndrome;   Mendelian Susceptibility to Mycobacterial Disease;   Common Variable Immune Deficiency (CVID)
Intervention: Biological: CD3/CD19 negative allogeneic hematopoietic stem cells

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.